Can understand the frustration & I imagine it is felt by many, including those within the company. However, those within the company have been privy to communications with FDA. AGM feedback from both Swedish & Itescu were positive about moving forward. Timelines are guesstimates. Mesoblast going it alone for gvhd - that will pay dividends in the long term!
FDA criticized by congress, page-13
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
92.5¢ |
Change
0.020(2.21%) |
Mkt cap ! $1.050B | |||
| Open | High | Low | Value | Volume |
| 93.0¢ | 93.5¢ | 90.5¢ | $2.551M | 2.764M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 31 | 88431 | 92.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 92.5¢ | 103097 | 22 |
View Market Depth
| Last trade - 12.40pm 07/08/2024 (20 minute delay) ? |
| MSB (ASX) Chart |